A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HDACi / histone deacetylases

[Related PubMed/MEDLINE]
Total Number of Papers: 39
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HDACi  (>> Co-occurring Abbreviation)
Long Form:   histone deacetylases
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Investigation of reversible histone acetylation and dynamics in gene expression regulation using 3D liver spheroid model. ---
2022 Valproate Targets Mammalian Gastrulation Impairing Neural Tissue Differentiation and Development of the Placental Source In Vitro. TSA, VPA
2021 Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells. CAR, UCC
2021 Histone Deacetylase Inhibitor Trichostatin A Reduces Endothelial Cell Proliferation by Suppressing STAT5A-Related Gene Transcription. HUVECs, STAT5A, TSA
2021 Pre-Senescence Induction in Hepatoma Cells Favors Hepatitis C Virus Replication and Can Be Used in Exploring Antiviral Potential of Histone Deacetylase Inhibitors. DAAs, HCV, HTAs
2018 Deacetylation of Histone H4 Accompanying Cardiomyogenesis is Weakened in HDAC1-Depleted ES Cells. dn, EBs, mESCs, TSA, WT
2018 Enhancement of adenovirus infection and adenoviral vector-mediated gene delivery by bromodomain inhibitor JQ1. BET
2018 Epigenetics in Metastatic Breast Cancer: Its Regulation and Implications in Diagnosis, Prognosis and Therapeutics. BC, MBC, miRNA
2018 HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis. CMC, ELISA, GOF, IL, PBMCs, STAT-1
10  2018 Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance. PDKi
11  2017 Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy. CTLA-4, mAbs
12  2017 Epigenetic Modifiers Facilitate Induction and Pluripotency of Porcine iPSCs. piPSCs
13  2016 Class I histone deacetylases regulate p53/NF-kappaB crosstalk in cancer cells. CLL, HDACs
14  2016 Epigenetic Drugs for Multiple Sclerosis. MS
15  2016 Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells. MLKL, VPA
16  2016 Generation and Assessment of Fusions Between HDACi and TKi. TKI
17  2016 HDAC inhibitors cause site-specific chromatin remodeling at PU.1-bound enhancers in K562 cells. DHS
18  2016 SIRT1 is a critical regulator of K562 cell growth, survival, and differentiation. MK, SIRTs
19  2015 Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignancies. HDAC
20  2015 Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases. ---
21  2014 Histone deacetylase 1 and 3 regulate the mesodermal lineage commitment of mouse embryonic stem cells. ESCs, HDACs, TSA
22  2014 Stability of single copy transgene expression in CHOK1 cells is affected by histone modifications but not by DNA methylation. RMCE
23  2013 Different effect of sodium butyrate on cancer and normal prostate cells. ---
24  2012 Hypothesis: butyrate is not an HDAC inhibitor, but a product inhibitor of deacetylation. ---
25  2012 Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity. VPA
26  2012 The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD. ED/ID, PD
27  2011 A proteomic analysis of differential cellular responses to the short-chain fatty acids butyrate, valerate and propionate in colon epithelial cancer cells. HCA, IFs, MTs, SCFAs
28  2011 Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome. RSTS
29  2010 Pre- and postimplantation development of swine-cloned embryos derived from fibroblasts and bone marrow cells after inhibition of histone deacetylases. BMC, FF, SCNT, TSA
30  2010 Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma. MCL
31  2010 The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells. FADD, GBM, ING1, TSA
32  2009 HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression. ---
33  2009 SUV39h-independent association of HP1 beta with fibrillarin-positive nucleolar regions. HP1
34  2008 Histone deacetylase regulation of immune gene expression in tumor cells. ---
35  2007 A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors. PRAME, RA, RARalpha
36  2007 p21waf1/Cip1 partially mediates apoptosis in hepatocellular carcinoma cells. 4-PB, TSA
37  2006 Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases. ---
38  2005 Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy. HCC, VA
39  2001 PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. DBDs, LBDs, RXRs, TRs